PNC Financial Services Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $115K | Sell |
|
|||||
|
2025
Q2 | $90.3K | Sell |
|
|||||
|
2025
Q1 | $96.3K | Sell |
|
|||||
|
2024
Q4 | $85.1K | Sell |
|
|||||
|
2024
Q3 | $268K | Buy |
|
|||||
|
2024
Q2 | $268K | Sell |
|
|||||
|
2024
Q1 | $415K | Sell |
|
|||||
|
2023
Q4 | $332K | Sell |
|
|||||
|
2023
Q3 | $370K | Sell |
|
|||||
|
2023
Q2 | $368K | Buy |
|
|||||
|
2023
Q1 | $150K | Buy |
|
|||||
|
2022
Q4 | $151K | Sell |
|
|||||
|
2022
Q3 | $122K | Buy |
|
|||||
|
2022
Q2 | $112K | Sell |
|
|||||
|
2022
Q1 | $108K | Buy |
|
|||||
|
2021
Q4 | $153K | Buy |
|
|||||
|
2021
Q3 | $107K | Sell |
|
|||||
|
2021
Q2 | $138K | Sell |
|
|||||
|
2021
Q1 | $162K | Buy |
|
|||||
|
2020
Q4 | $119K | Buy |
|
|||||
|
2020
Q3 | $115K | Buy |
|
|||||
|
2020
Q2 | $114K | Buy |
|
|||||
|
2020
Q1 | $131K | Sell |
|
|||||
|
2019
Q4 | $246K | Buy |
|
|||||
|
2019
Q3 | $289K | Sell |
|
|||||
|
2019
Q2 | $339K | Buy |
|
|||||
|
2019
Q1 | $82K | Buy |
|
|||||
|
2018
Q4 | $49K | Buy |
|
|||||
|
2018
Q3 | $57K | Buy |
|
|||||
|
2018
Q2 | $66K | Buy |
|
|||||
|
2018
Q1 | $56K | Sell |
|
|||||
|
2017
Q4 | $70K | Buy |
|
|||||
|
2017
Q3 | $52K | Sell |
|
|||||
|
2017
Q2 | $3.33M | Sell |
|
|||||
|
2017
Q1 | $3.53M | Sell |
|
|||||
|
2016
Q4 | $4.5M | Buy |
|
|||||
|
2016
Q3 | $4.56M | Buy |
|
|||||
|
2016
Q2 | $3.43M | Buy |
|
|||||
|
2016
Q1 | $1.8M | Buy |
|
|||||
|
2015
Q4 | $2K | Hold |
|
|||||
|
2015
Q3 | $2K | Buy |
|
|||||
|
2015
Q2 | $3K | Buy |
|
|||||
|
2015
Q1 | $2K | Sell |
|
|||||
|
2014
Q4 | $3K | Buy |
|